The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of cetuximab-irinotecan rechallenge versus regorafenib in RAS wild-type metastatic colorectal cancer.
 
Hao Chen
No Relationships to Disclose
 
Tao Jiang
No Relationships to Disclose
 
Han Wang
No Relationships to Disclose
 
JW Zheng
No Relationships to Disclose
 
Bin Du
No Relationships to Disclose
 
Xiaojiao Weng
No Relationships to Disclose
 
Na Yao
No Relationships to Disclose
 
Yingjiao Zhu
No Relationships to Disclose
 
Qing Liu
No Relationships to Disclose
 
Fangyu Lin
No Relationships to Disclose
 
Xinli Wang
No Relationships to Disclose
 
Xiaoyan Lin
No Relationships to Disclose